FABP9 as a potential therapeutic target for tumors: Inhibiting FABP9 can reduce tumor cell invasiveness, especially in FABP9-overexpressing liver cancer, and targeted intervention may become a new strategy[156]. Here, FABP9 is linked to neoplasm.